US2017016046A1PendingUtilityA1
Methods and Compositions for Isolating Polynucleotides
Est. expiryMar 26, 2030(~3.7 yrs left)· nominal 20-yr term from priority
Inventors:Vladimir Makarov
C12Q 1/6827C12Q 1/6806C12Q 1/6869C12Q 1/683C12Q 1/6876C12Q 1/6846C12Q 1/682C12Q 1/6862C12Q 1/6816C12Q 1/686C12Q 1/6813C12Q 1/6844
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of isolating target double-stranded polynucleotides with internal single-stranded regions are provided. Compositions and kits comprising double-stranded polynucleotides with internal single-stranded regions are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of selecting a target double-stranded polynucleotide molecule, said target have an internal destabilized region, wherein the destabilized region comprises (i) an intact polynucleotide strand in the target double-stranded polynucleotide and (ii) a strand substantially complementary to the intact strand and with a plurality of abasic sites or mismatches, said method comprising the steps of:
(a) contacting the internal destabilized region with a single-stranded polynucleotide, said single-stranded polynucleotide comprising a linker portion and a capture portion, said linker portion having a sequence sufficiently complementary to hybridize to the intact polynucleotide strand of the destabilized region of the target under appropriate conditions, and said capture portion does not hybridize to the destabilized region of the target; and (b) contacting the target with a capture substance that interacts with the capture portion of the single-stranded polynucleotide to select the target.
2 . A method of selecting a target double-stranded polynucleotide molecule, said target having an internal single-stranded region, said method comprising the steps of:
(a) contacting the internal single-stranded region with a single-stranded polynucleotide, said single-stranded polynucleotide comprising a linker portion and a capture portion, said linker portion having a sequence sufficiently complementary to hybridize to the single-stranded region of the target under appropriate conditions, and said capture portion does not hybridize to the single-stranded region of the target; and (b) contacting the target with a capture substance that interacts with the capture portion of the single-stranded polynucleotide to select the target, wherein the single stranded polynucleotide is not ligated to the target.
3 . A method of selecting a target double-stranded polynucleotide molecule, said target having an internal single-stranded region, said method comprising the steps of:
(a) generating the single-stranded region in the target double-stranded polynucleotide molecule by a process selected from the group consisting of nick-translation DNA synthesis and nick-mediated strand-displacement DNA synthesis, (b) contacting the internal single-stranded region with a single-stranded polynucleotide, said single-stranded polynucleotide comprising a linker portion and a capture portion, said linker portion having a sequence sufficiently complementary to hybridize to the single-stranded region of the target under appropriate conditions, and said capture portion does not hybridize to the single-stranded region of the target; and (c) contacting the target with a capture substance that interacts with the capture portion of the single-stranded polynucleotide to select the target.
4 . The method of claim 1 , 2 , or 3 wherein the single-stranded polynucleotide is allele-specific.
5 . The method of claim 1 , 2 , or 3 wherein the single-stranded polynucleotide is haplotype-specific.
6 . The method of any one of claims 2 to 5 wherein the internal single-stranded region is a flap.
7 . The method of any one of claims 2 to 5 wherein the internal single-stranded region is a gap.
8 . The method of any of claims 1 to 7 further comprising the step of isolating the target polynucleotide molecule selected in step (b).
9 . The method of any of claims 1 to 8 further comprising the step of extending the capture portion and/or the linker portion of the single-stranded polynucleotide.
10 . The method of claim 9 wherein extending the single-stranded polynucleotide adds a specific sequence.
11 . The method of claim 10 wherein the single-stranded polynucleotide is extended by rolling circle amplification.
12 . The method of any of claims 9 to 11 wherein extending the single-stranded polynucleotide adds a sequence that interacts with the capture substance.
13 . The method of any one of claims 1 to 12 further comprising the step of cleaving a phosphodiester bond of the target polynucleotide molecule.
14 . The method of any one of claim 1 , 2 or 4 - 10 , further comprising the step of generating the single-stranded region in the target double-stranded polynucleotide molecule by cleaving a phosphodiester bond of the target double-stranded polynucleotide molecule and removing one or more bases in a single strand of the target polynucleotide molecule adjacent the phosphodiester bond that was cleaved.
15 . The method of any one of claim 1 , 4 , 5 , or 8 - 14 , further comprising the step of generating the internal destabilized region by nick-translation DNA synthesis and treating with Uracil-DNA glycosylase (UDG).
16 . The method of any one of claim 2 or 6 - 14 , further comprising the step of generating the single-stranded region in the target double-stranded polynucleotide molecule by a process selected from the group consisting of nick-mediated exonuclease DNA degradation, nick-translation DNA synthesis, and nick-mediated strand-displacement DNA synthesis, after the phosphodiester bond is cleaved.
17 . The method of any one of claims 1 to 16 wherein the target polynucleotide molecule is released from the capture substance.
18 . The method of claim 17 wherein the target double-stranded polynucleotide molecule is released by enzymatic degradation of the capture portion and capture substance.
19 . The method of any one of claims 13 to 18 wherein the phosphodiester bond is cleaved by a nicking endonuclease.
20 . The method of claim 19 wherein the nicking endonuclease is selected from the group consisting of Nb.BbvCI, Nb.BsmI, Nb.BsrDI, Nb.BtsI, Nt.AlwI, Nt.BbvCI, Nt.BsmAI, Nt.BspQI, Nt.BstNBI and Nt.CviPII.
21 . The method of claim 19 or 20 wherein the nicking endonuclease is heat inactivated or removed after the phosphodiester bond is cleaved.
22 . The method of any of claims 1 through 21 wherein the capture substance comprises a polynucleotide probe having a sequence sufficiently complementary to hybridize to the capture portion of the single-stranded polynucleotide.
23 . The method of claim 22 wherein the polynucleotide probe hybridizes to the sequence added to the single stranded polynucleotide.
24 . The method of claim 22 or 23 wherein the polynucleotide probe is covalently attached to a bead.
25 . The method of any one of claims 1 to 24 wherein the capture substance comprises:
(a) a polynucleotide probe having a sequence sufficiently complementary to hybridize to the capture portion of the single-stranded polynucleotide, said probe covalently attached to a first binding partner; and
(b) a second binding partner.
26 . The method of claim 25 wherein the second binding partner is attached to a bead.
27 . The method of claim 25 or 26 wherein the first binding partner comprises biotin and the second binding partner comprises streptavidin.
28 . The method of any one of claims 24 to 27 wherein the bead is magnetic.
29 . The method of any one of claims 1 to 28 wherein the capture substance is immobilized on a solid support.
30 . The method of claim 29 wherein the solid support is selected from the group consisting of a polypropylene tube, a capillary tube, and a glass slide.
31 . A composition comprising a substantially double-stranded polynucleotide molecule with an internal destabilized region that is associated with a single-stranded polynucleotide, said destabilized region comprising (i) an intact polynucleotide strand in the target double-stranded polynucleotide and (ii) a strand substantially complementary to the intact strand and with a plurality of abasic sites or mismatches, said single-stranded polynucleotide comprising a linker portion and a capture portion, said linker portion sufficiently complementary to the intact strand of the destabilized region to allow the linker portion and the intact strand to hybridize, and said capture portion not complementary to the substantially double-stranded polynucleotide molecule.
32 . The composition of claim 31 further comprising a polynucleotide probe hybridized to the capture portion of the single-stranded polynucleotide.
33 . The composition of claim 32 further comprising a bead.
34 . The composition of claim 33 wherein the polynucleotide probe is covalently attached to the bead.
35 . The composition of claim 34 wherein the bead is magnetic.
36 . The composition of claim 32 wherein the polynucleotide probe is biotinylated.
37 . The composition of claim 36 further comprising a streptavidin-coated bead.
38 . A DNA selection kit comprising: (a) a single-stranded polynucleotide comprising a linker portion and a capture portion, said linker portion having a sequence sufficiently complementary to hybridize to a single-stranded region of a substantially double-stranded target polynucleotide molecule under appropriate conditions, and said capture portion not complementary to the single-stranded region of the target; (b) a capture substance that interacts with the capture portion of the single-stranded polynucleotide; and (c) a DNA polymerase.
39 . The kit of claim 38 further comprising a nicking endonuclease.
40 . The kit of claim 39 wherein the nicking endonuclease is selected from the group consisting of Nb.BbvCI, Nb.BsmI, Nb.BsrDI, Nb.BtsI, Nt.AlwI, Nt.BbvCI, Nt.BsmAI, Nt.BspQI, Nt.BstNBI and Nt.CviPII.
41 . The kit of any one of claims 38 to 40 further comprising an exonuclease.
42 . The kit of claim 41 wherein the exonuclease is a 5′ exonuclease or a 3′ exonuclease.
43 . The kit of any one of claims 38 to 42 further comprising a DNA polymerase.
44 . The kit of any of claims 38 to 43 further comprising a dNTP mix, said dNTP mix comprising dTTP, dATP, dCTP, and dGTP.
45 . The kit of any of claims 38 to 43 further comprising a dNTP mix, said dNTP mix comprising dUTP, dATP, dCTP, and dGTP.
46 . The kit of claim 45 further comprising dTTP.
47 . The kit of any of claims 38 to 46 further comprising a uracil-DNA Glycosylase (UDG) enzyme and an abasic endonuclease.
48 . The kit of claim 47 wherein the abasic endonuclease is selected from the group consisting of APE1, endonuclease III(Nth), endonuclease IV, endonuclease VIII, T4 endonuclease V, Tma endonuclease III, and Tth endonuclease IV.
49 . The kit of any one of claims 38 to 48 wherein the capture substance comprises a polynucleotide probe having a sequence sufficiently complementary to hybridize to the capture portion of the single-stranded polynucleotide.
50 . The kit of claim 49 wherein the polynucleotide probe is covalently attached to a bead.
51 . The kit of claim 49 wherein the polynucleotide probe is covalently attached to biotin.
52 . The kit of claim 51 wherein the capture substance further comprises a streptavidin-coated bead.
53 . The kit of claim 50 or 52 wherein the bead is magnetic.
54 . A method of selecting a target double-stranded polynucleotide molecule, said target having an internal single-stranded region, said method comprising the step of:
(a) generating the single-stranded region in the target double-stranded polynucleotide molecule by nick-mediated strand-displacement DNA synthesis (b) contacting the internal single-stranded region with a capture substance that interacts with the internal single-stranded polynucleotide to select the target.
55 . The method of claim 54 wherein the internal single-stranded region is a flap.
56 . The method of claim 54 or 55 further comprising the step of isolating the target polynucleotide molecule.
57 . The method of any of claims 54 to 56 further comprising the step of extending the single-stranded region.
58 . The method of claim 57 wherein extending the single-stranded region adds a specific sequence.
59 . The method of claim 57 or 58 wherein extending the single-stranded region adds a sequence that interacts with the capture substance.
60 . The method of any of claims 57 to 59 wherein the single-stranded region is extended by rolling circle amplification.
61 . The method of any one of claims 54 to 60 further comprising the step of cleaving a phosphodiester bond of the target polynucleotide molecule.
62 . The method of any one of claims 54 to 61 wherein the target polynucleotide molecule is released from the capture substance.
63 . The method of claim 62 wherein the target double-stranded polynucleotide molecule is released by enzymatic degradation of the capture portion and capture substance.
64 . The method of claim 61 wherein the phosphodiester bond is cleaved by a nicking endonuclease.
65 . The method of claim 64 wherein the nicking endonuclease is selected from the group consisting of Nb.BbvCI, Nb.BsmI, Nb.BsrDI, Nb.BtsI, Nt.AlwI, Nt.BbvCI, Nt.BsmAI, Nt.BspQI, Nt.BstNBI and Nt.CviPII.
66 . The method of claim 64 or 65 wherein the nicking endonuclease is heat inactivated or removed after the phosphodiester bond is cleaved.
67 . The method of any of claims 54 through 66 wherein the capture substance comprises a polynucleotide probe having a sequence sufficiently complementary to hybridize to the internal single-stranded region.
68 . The method of any of claims 57 to 67 wherein the polynucleotide probe hybridizes to the sequence added to the single stranded polynucleotide.
69 . The method of claim 67 or 68 wherein the polynucleotide probe is covalently attached to a bead.
70 . The method of any one of claims 54 to 69 wherein the capture substance comprises:
(a) a polynucleotide probe having a sequence sufficiently complementary to hybridize to the internal single-stranded region, said probe covalently attached to a first binding partner; and
(b) a second binding partner.
71 . The method of claim 70 wherein the second binding partner is attached to a bead.
72 . The method of claim 70 or 71 wherein the first binding partner comprises biotin and the second binding partner comprises streptavidin.
73 . The method of any one of claims 69 to 72 wherein the bead is magnetic.
74 . The method of any one of claims 62 to 73 wherein the capture substance is immobilized on a solid support.
75 . The method of claim 74 wherein the solid support is selected from the group consisting of a polypropylene tube, a capillary tube, and a glass slide.Join the waitlist — get patent alerts
Track US2017016046A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.